Gennaro Daniele

18PUBLICATIONS
64CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedArtificial life and complex adaptive systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jan 31, 2026
Main factors associated with variability in the assessment of the objective response rate. A re-analysis of the PHEREXA phase 3 clinical trial.

Gennaro Daniele, Tommaso Giovagnoli, Pierluigi Navarra

|Jan 09, 2026
TAPISTRY: A Phase II Study of Atezolizumab in Patients with Tumor Mutational Burden-High Tumors.

David M Thomas, Jeong Eun Kim, Fabrice Barlesi

|Oct 17, 2025
Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer.

Xiuning Le, Tae Min Kim, Herbert H Loong

|Feb 26, 2025
Implications of Fumarate Hydratase Deficiency (FHD) and Cancer Risk: A Window into the Clinical and Oncological Implications of a Rare Disorder in Gynecology.

Marco D'Indinosante, Sara Lardino, Matteo Bruno

|Dec 17, 2024
Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature.

Marco Filetti, Mario Occhipinti, Alessio Cirillo

|Oct 07, 2024
Impact of Comprehensive Genome Profiling on the Management of Advanced Non-Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program.

Antonio Vitale, Luca Mastrantoni, Jacopo Russo

Pageof 3

Frequent Collaborators

6 joint publications

Antonella Pietragalla

6 joint publications

Simona Duranti

6 joint publications

Camilla Nero

6 joint publications

Pasquale Lombardi